tiprankstipranks
Advertisement
Advertisement

RIGL Stock Latest News

Is RIGL a Buy, Before Earnings?
Pre-EarningsIs RIGL a Buy, Before Earnings?
2d ago
RIGL
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating
PremiumRatings
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating
13d ago
RIGL
Rigel Regains Rights as Eli Lilly Ends Collaboration
PremiumCompany Announcements
Rigel Regains Rights as Eli Lilly Ends Collaboration
13d ago
8K
RIGL
Rigel Pharmaceuticals Balances Breakout Growth With Caution
PremiumCompany Announcements
Rigel Pharmaceuticals Balances Breakout Growth With Caution
1M ago
RIGL
Rigel Pharmaceuticals’ pralsetinib shows efficacy in NSCLC clinical trial
PremiumThe Fly
Rigel Pharmaceuticals’ pralsetinib shows efficacy in NSCLC clinical trial
1M ago
RIGL
Rigel’s New Olutasidenib Interaction Study Signals Long-Game Strategy for RIGL Investors
PremiumCompany AnnouncementsRigel’s New Olutasidenib Interaction Study Signals Long-Game Strategy for RIGL Investors
2M ago
RIGL
Rigel Pharmaceuticals’ Fast Track Ambitions Face Significant FDA Uncertainty
Premium
Company Announcements
Rigel Pharmaceuticals’ Fast Track Ambitions Face Significant FDA Uncertainty
2M ago
RIGL
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $279.31M
Premium
The Fly
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $279.31M
2M ago
RIGL
Rigel Pharmaceuticals reports Q4 EPS $13.54 with items, consensus $1.20
PremiumThe Fly
Rigel Pharmaceuticals reports Q4 EPS $13.54 with items, consensus $1.20
2M ago
RIGL
Is RIGL a Buy, Before Earnings?
PremiumPre-Earnings
Is RIGL a Buy, Before Earnings?
2M ago
RIGL
Rigel Pharmaceuticals Appoints Michael P. Miller to Board
PremiumCompany Announcements
Rigel Pharmaceuticals Appoints Michael P. Miller to Board
3M ago
8K
RIGL
Rigel Pharmaceuticals price target raised to $71 from $69 at Citi
PremiumThe Fly
Rigel Pharmaceuticals price target raised to $71 from $69 at Citi
4M ago
RIGL
Rigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
PremiumRatingsRigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
4M ago
RIGL
Rigel Announces Strong Preliminary 2025 Results and Outlook
Premium
Company Announcements
Rigel Announces Strong Preliminary 2025 Results and Outlook
4M ago
8K
RIGL
Rigel Pharmaceuticals sees Q4 revenue $69.8M, consensus $66.44M
Premium
The Fly
Rigel Pharmaceuticals sees Q4 revenue $69.8M, consensus $66.44M
4M ago
RIGL
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $291.58M
PremiumThe Fly
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $291.58M
4M ago
RIGL
Rigel Pharmaceuticals Reports Promising Phase 1b Study Results
PremiumCompany Announcements
Rigel Pharmaceuticals Reports Promising Phase 1b Study Results
5M ago
8K
RIGL
Rigel’s Promising Pipeline and Strategic Advancements Justify Buy Rating
PremiumRatings
Rigel’s Promising Pipeline and Strategic Advancements Justify Buy Rating
5M ago
RIGL
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891
PremiumThe Fly
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891
5M ago
RIGL
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
PremiumThe FlyRigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
6M ago
RIGL
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
Premium
Company Announcements
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
6M ago
RIGL
Rigel Pharmaceuticals upgraded to Buy at Jefferies on strong execution
Premium
The Fly
Rigel Pharmaceuticals upgraded to Buy at Jefferies on strong execution
6M ago
RIGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >